Founded in December 2000 and based in Shanghai, WuXi (pronounced Woo-See) PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services ranging from discovery chemistry to biological services and manufacturing of APIs for R&D use.

WuXi PharmaTech assists its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions. Our management team consists of Western-trained Ph.D.s and MBAs with experience in drug R&D methodologies and Western-style business practices. Collectively, our senior management has more than 200 patents pending or granted, published more than 800 publications and has an average of 14 years of experience working in major international pharmaceutical and biotechnology companies.

With over 2,100 scientific staff members, a 630,000 sq. ft. Shanghai Waigaoqiao Free Trade Zone research facility, a 220,000 sq. ft. cGMP-quality manufacturing plant in Jinshan District, Shanghai, a new 130,000 sq. ft. Tianjin research facility, and a 323,449 sq. ft. Suzhou preclinical service facility under construction, WuXi PharmaTech is well-positioned to offer its customers high quality services along the drug discovery value chain. In 2007, its 80 customers included nine of the world's top ten pharmaceutical companies by revenue.